Elsilimomab
Elsilimomab
Elsilimomab (pronunciation: el-si-li-mo-mab) is a type of monoclonal antibody used in the field of oncology for the treatment of certain types of cancer.
Etymology
The term "Elsilimomab" is derived from the International Nonproprietary Names (INN) system for pharmaceutical substances. The "-mab" suffix indicates that it is a monoclonal antibody, while the "Elsi-" prefix is a unique identifier for this specific drug.
Usage
Elsilimomab is used in the treatment of certain types of cancer. It works by binding to specific proteins on the surface of cancer cells, which helps the immune system to recognize and destroy these cells.
Related Terms
- Monoclonal antibody: A type of protein made in the lab that can bind to substances in the body, including cancer cells.
- Oncology: The branch of medicine that deals with the prevention, diagnosis, and treatment of cancer.
- Cancer: A group of diseases characterized by the uncontrolled growth and spread of abnormal cells.
See Also
External links
- Medical encyclopedia article on Elsilimomab
- Wikipedia's article - Elsilimomab
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski